Siemens Healthineers Splits Fast-Growing Asia Pacific Operations into Two Regions

Siemens HealthineersSiemens Healthineers is splitting its Asia Pacific operations into two to allow both China and the rest of the region to achieve their full potential. China, now its own region, continues to be headed by Jerry Wang, while the new Asia Pacific Japan region is headed by Vy Tran, formerly Varian's chief compliance and quality officer.

The changes complete and strengthen the following the promotion of Elisabeth Staudinger, former head of Asia Pacific, to the Siemens Healthineers managing board, where she retains responsibility at board level for the two new regions.

"It makes sense to allow diverse and fast-growing Asia Pacific markets to flourish in their own right, while establishing China, set to be the biggest global market in medical technology by 2030, as its own region," said Staudinger. "In Vy Tran and Jerry Wang, we have two strong leaders who will ensure the new regions excel."

The former Asia Pacific region accounted for 27 percent of Siemens Healthineers' total revenue in fiscal year 2021, at EUR 4.82 billion (USD 4.65 billion). Within the region, China's revenues were EUR 2.35 billion, or almost half.

Vy Tran, who will move from California to Singapore at the end of December, said: "I am thrilled to take on this new opportunity. I look forward to working with the team to further expand growth and access to care in this very exciting region."

Jerry Wang, who has headed the operations of Siemens Healthineers in China since 2018, said: "As we strengthen our role as a trusted partner of the Chinese healthcare system and its patients, I welcome this opportunity to focus even more clearly on China’s most urgent healthcare needs."

Tran joined Varian, now a Siemens Healthineers company, in 1998 and has held leadership positions in regulatory affairs, quality and compliance. She has been key to sharpening Varian's focus on cancer care through acquisitions and divestments, and also in the combination of Varian and Siemens Healthineers. Her areas of expertise include global regulation, ethics and trade.

Wang has over 20 years of experience in the medical technology industry. He began in sales marketing with Siemens Healthineers in 2001, rising to general manager of Diagnostic Imaging and Advanced Therapies in China. After spells with Sorin Group and Philips - whose China business he led - Wang returned to Siemens Healthineers in 2018.

About Siemens Healthineers

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company's foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers' ability to provide high-quality, efficient care. In fiscal 2021, which ended on September 30, 2021, Siemens Healthineers, which has approximately 66,000 employees worldwide, generated revenue of €18.0 billion and adjusted EBIT of €3.1 billion.

Most Popular Now

Artificial Intelligence: Unexpected Resu…

Artificial intelligence (AI) is on the rise. Until now, AI applications generally have "black box" character: How AI arrives at its results remains hidden. Prof. Dr. Jürgen Bajorath, a cheminformatics...

Printed Robots with Bones, Ligaments, an…

3D printing is advancing rapidly, and the range of materials that can be used has expanded considerably. While the technology was previously limited to fast-curing plastics, it has now been...

AI identifies Non-Smokers at High Risk f…

Using a routine chest X-ray image, an artificial intelligence (AI) tool can identify non-smokers who are at high risk for lung cancer, according to a study being presented next week...

Orchestrating the New World of AI in Hea…

Orion Health's UK and Ireland Customer Conference 2023 focused on the future potential and immediate, practical application of AI to healthcare - and gave delegates a first look at the...

Study Reveals Bias in AI Tools when Diag…

Machine learning algorithms designed to diagnose a common infection that affects women showed a diagnostic bias among ethnic groups, University of Florida researchers found. While artificial intelligence (AI) tools offer...

Researchers Take New AI Approach to Anal…

Researchers at Karolinska Institutet and SciLifeLab in Sweden have combined artificial intelligence (AI) techniques used in satellite imaging and community ecology to interpret large amounts of data from tumour tissue...

Medical AI Tool from UF, NVIDIA gets Hum…

A new artificial intelligence (AI) computer program created by researchers at the University of Florida and NVIDIA can generate doctors' notes so well that two physicians couldn't tell the difference...

Commission Opens Calls to Invest €42 Mil…

Today, the European Commission opened a new set of calls for proposals under the 2023-2024 Work Programmes of the Digital Europe Programme with a focus on advanced digital skills. The calls...

Bayer Championing Advancements in Radiol…

Bayer continues to advance its comprehensive Radiology portfolio with progress in the development pipeline of its investigational contrast agent as well as new innovations in the area of Artificial Intelligence...

MEDICA and COMPAMED: Medical Technology …

13 - 16 November 2023, Düsseldorf, Germany. After four days of business, MEDICA and COMPAMED in Düsseldorf delivered impressive confirmation that they are excellent platforms for the worldwide medical technology business...

AI Predicts Developmental Paths in Prema…

Researchers at UMC Utrecht have developed an AI model to predict long-term outcome in extremely premature babies early in life. The model can identify which infants might face intellectual disability...

AI Paves Way for New Medicines

A team of researchers from LMU, ETH Zurich, and Roche Pharma Research and Early Development (pRED) Basel has used artificial intelligence (AI) to develop an innovative method that predicts the...